Esteve Pharmaceuticals, S.A.
6 products tracked · names used in filings: Esteve Pharmaceuticals, S.A.
Upcoming milestones
No upcoming milestones listed.
Recent milestones
No recent milestones.
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Ketoconazole Esteve (previously Ketoconazole HRA) ketoconazole | Authorised | 2014-11-18 |
| 🇪🇺 | Caprelsa vandetanib | Authorised | 2012-02-16 |
| 🇪🇺 | Mepact mifamurtide | Authorised | 2009-03-06 |
| 🇪🇺 | Increlex mecasermin | Authorised | 2007-08-02 |
| 🇪🇺 | Nodetrip (previously Xeristar) duloxetine | Withdrawn | 2004-12-17 |
| 🇪🇺 | Lysodren mitotane | Authorised | 2004-04-28 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.